Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Ultragenyx
Company Monitoring Page for Ultragenyx
job ratings for Ultragenyx
09/09/20
industry:
Bio Tech/Pharma
job title:
Medical
company:
Ultragenyx
job rating:
7
Promising pipeline, great culture, mutual respect, transparent communication, collaboration amongst colleagues great and timely. Patient focused!
09/20/17
industry:
Bio-pharmaceutical
company:
Ultragenyx
job rating:
3
Mass confusion - no leadership, little regard for coming together and getting it done.
latest headlines for company on cafepharma
Ultragenyx says Angelman therapy is working, but safety questions remain
BioPharma Dive
Tue, 04/16/24 - 07:49 am
Tags:
Ultragenyx
,
Angelman Syndrome
,
GTX-102
Family of Henrietta Lacks sues Ultragenyx over use of HeLa cell line
BioPharma Dive
Sun, 08/13/23 - 02:25 pm
Tags:
Henrietta Lacks
,
Ultragenyx
,
legal
Roche drops antisense drug after seeing efficacy data, leaving Biogen, Ionis and Ultragenyx to duke it out
Fierce Biotech
Fri, 06/23/23 - 09:46 am
Tags:
Roche
,
Angelman Syndrome
,
antisense
,
Biogen
,
Ionis Pharmaceuticals
,
Ultragenyx
,
rugonersen
mRNA non-vaccine therapeutics field set to reach $2 billion by 2028
Clinical Trials Arena
Tue, 11/8/22 - 10:54 am
Tags:
MRNA
,
drug development
,
Moderna Therapeutics
,
Ultragenyx
,
Omega Therapeutics
,
BioNTech
,
cancer
,
OTX-2002
Unpacking Royalty Pharma
EP Vantage
Mon, 07/18/22 - 10:24 am
Tags:
Royalty Pharma
,
Ultragenyx
Ultragenyx strikes deal with struggling Abeona for rare disease gene therapy
BioPharma Dive
Tue, 05/17/22 - 10:30 pm
Tags:
Ultragenyx
,
Sanfillipo Syndrome
,
gene therapy
,
Abeona Therapeutics
Regeneron hands off ex-US rights for cholesterol disorder drug to rare disease specialist Ultragenyx
Endpoints
Fri, 01/7/22 - 10:36 am
Tags:
Regeneron
,
evinacumab
,
Ultragenyx
Ultragenyx granted go-ahead to up doses for Angelman antisense therapy that stalled after safety issues
Fierce Biotech
Wed, 01/5/22 - 10:32 pm
Tags:
Ultragenyx
,
GeneTx Biotherapeutics
,
Angelman Syndrome
,
clinical trials
,
antisense
,
GTX-102
The "Rare Disease Company Coalition" Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development to Support Continued Progress and Patient Access
Yahoo/Businesswire
Thu, 05/13/21 - 12:04 pm
Tags:
Rare Diseases
,
Rare Disease Company Coalition
,
drug development
,
drug discovery
,
Acceleron
,
Aeglea BioTherapeutics
,
Agios Pharmaceuticals
,
Alnylam
,
Harmony Biosciences
,
Orchard Therapeutics
,
Orphazyme
,
Sarepta Therapeutics
,
Taysha Gene Therapies
,
Ultragenyx
Ultragenyx earns 2 rare disease drug approvals—and a validated commercial strategy
Fierce Pharma
Fri, 01/29/21 - 10:00 am
Tags:
Ultragenyx
,
FDA
,
Crysvita
,
tumor-induced osteomalacia
,
Kyowa Kirin
,
Dojolvi
Biotech Mereo BioPharma pens $50M Ultragenyx deal for rare bone disease drug
Fierce Biotech
Fri, 12/18/20 - 11:41 am
Tags:
Mereo BioPharma
,
Ultragenyx
,
setrusumab
,
osteogenesis imperfecta
Ultragenyx pauses antisense trial after patients lose ability to walk
Fierce Biotech
Tue, 10/27/20 - 10:40 am
Tags:
Ultragenyx
,
clinical trials
,
GTX-102
,
antisense
Ultragenyx Pharma Wins FDA’s First Drug Nod for Rare Metabolic Disorder
Xconomy
Tue, 06/30/20 - 11:35 pm
Tags:
Ultragenyx
,
FDA
,
long-chain fatty acid oxidation disorders
,
Dojolvi
Ultragenyx's Crysvita scores FDA nod in 2nd ultra-rare bone disorder
Fierce Pharma
Thu, 06/18/20 - 08:31 pm
Tags:
Ultragenyx
,
Kyowa Kirin
,
Crysvita
,
FDA
,
tumor-induced osteomalacia
What Sanofi Might Buy With Its Regeneron Windfall
Barron's
Wed, 05/27/20 - 11:01 am
Tags:
Sanofi
,
Regeneron
,
M&A
,
gene therapy
,
Ultragenyx
,
Bluebird Bio
Ultragenyx shares jump on 'better than expected' gene therapy data
Fierce Biotech
Fri, 01/10/20 - 10:26 am
Tags:
Ultragenyx
,
clinical trials
,
gene therapy
,
DTX301
Ultragenyx gene therapy data disappoints investors
Biopharma Dive
Thu, 09/5/19 - 08:15 pm
Tags:
Ultragenyx
,
gene therapy
,
DTX401
,
glycogen storage disorder
,
clinical trials
Ultragenyx Inks a Partner-to-Buy Deal with GeneTx to Develop Treatment for Rare Genetic Syndrome
BioSpace
Thu, 08/15/19 - 12:20 pm
Tags:
Ultragenyx
,
GeneTx Biotherapeutics
,
Angelman Syndrome
,
M&A
Crysvita sales push Ultragenyx ahead for the quarter
BioCentury
Fri, 08/2/19 - 12:24 am
Tags:
Ultragenyx
,
Crysvita
,
earnings
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
Sun, 07/28/19 - 11:48 pm
Tags:
biotech
,
earnings
,
Immunic
,
Alkermes
,
Conatus
,
Aevi Genomic
,
Tricida
,
Curis
,
Ultragenyx
,
Leap Therapeutics
,
Cidara Therapeutics
,
Akcea
,
Spark Therapeutics
,
Eli Lilly
,
AnaptysBio
,
clinical trials
Pages
1
2
3
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.